- Details
- In this conversation, Wei Shen Tan joins Ashish Kamat in discussing findings on BCG unresponsive bladder cancer patients, comparing bladder-sparing treatment and early radical cystectomy. The study they discuss shows no difference in overall or cancer-specific survival, suggesting a bladder-sparing approach may be suitable for selected patients. However, early salvage cystectomy is recommended if...
|
- Details
- Matthew Cooperberg and Daniel Lin discuss the update to the American Urological Association's (AUA) prostate cancer screening guideline in this discussion. They highlight the collaborative effort involved in the guideline update, involving a large group of experts and reviewers. They compare the AUA's process with that of the National Comprehensive Cancer Network (NCCN) and discuss the systematic...
|
- Details
- Ashley Ross and Jim Hu discuss the use of genomic classifiers, specifically the Decipher Genomic Classifier, in the management of localized prostate cancer. They review its performance in larger datasets and its association with prostate cancer outcomes. The conversation also delves into the use of the Decipher Prostate Biopsy Test in men with favorable risk disease undergoing conservative managem...
|
- Details
- In this presentation, Amanda McCormac discusses a study that aimed to identify clinical factors associated with the safe deployment of a 16 French ureteral access sheath. The study used a novel UCI force-sensing device during ureteral access sheath insertion among 238 patients undergoing ureteroscopy. The results showed that safe passage of a 16 French access sheath is reproducibly achievable, esp...
|
- Details
- Sam Chang speaks with Jeannie Hoffman-Censits about the AUA guidelines on upper tract urothelial carcinoma. They discussed how multidisciplinary panels are important in creating such guidelines and the variability in the treatment of patients with upper tract disease. Dr. Hoffman-Censits mentioned the need for more streamlined and consistent guideline-based approaches to these patients to ensure t...
|
- Details
- Jonathan Coleman, chair of the AUA guidelines for upper tract urothelial carcinoma, joins Sam Chang in discussing the process of putting together these guidelines, including the use of biostatisticians to collect data from retrospective and prospective studies. The guidelines aim to provide a standardized process for evaluating, diagnosing, and risk-stratifying patients with upper tract urothelial...
|
- Details
- Larissa Bresler joins Samuel Washington to discuss the AUA Diversity and Inclusion Committee's objectives to increase diversity in urology and improve health outcomes for minorities. Dr. Bresler also discusses the Future Urology Talent from Underrepresented Entities (FUTURE) program, a mentorship program that targets students from underrepresented groups and invites them into the urologic communit...
|
- Details
- Sam Chang led a group discussion highlighting a panel presentation on management evaluation, surveillance, and follow-up individuals with upper tract urothelial carcinoma, a presentation that took place at the AUA 2023. Surena Matin, Jay Raman, Sima Porten, and Tomonori Habuch join in a discussion on topics including lymphadenectomy for upper tract urothelial cancer, risk stratification, sequencin...
|
- Details
- David Crawford joins Phillip Koo in a discussion on the Radiographic Assessments for Detection of Advanced Recurrence (RADAR) articles, which aimed to improve the appropriate utilization of imaging in prostate cancer patients. The RADAR articles looked at three areas: biochemical failure, newly diagnosed disease, and castrate-resistant non-metastatic disease. They suggested appropriate triggers fo...
|
- Details
- Zachary Klaassen is joined by Neil Mariados, the lead author on both the SpaceOAR™ and Barrigel® trials to discuss rectal spacing, which is used in radiation therapy to reduce rectal toxicity in prostate cancer patients. Rectal spacing involves inserting a gel between the rectum and the prostate to create a space that reduces the dose to the rectum during radiation. They compare the two FDA-approv...
|
